Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS

Detalles Bibliográficos
Autores principales: Russell, Lindsey, Armstrong, David, Sanchez, María Inés Pinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212270/
http://dx.doi.org/10.1016/S0016-5085(22)60871-0
_version_ 1784730544185016320
author Russell, Lindsey
Armstrong, David
Sanchez, María Inés Pinto
author_facet Russell, Lindsey
Armstrong, David
Sanchez, María Inés Pinto
author_sort Russell, Lindsey
collection PubMed
description
format Online
Article
Text
id pubmed-9212270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92122702022-06-22 Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS Russell, Lindsey Armstrong, David Sanchez, María Inés Pinto Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212270/ http://dx.doi.org/10.1016/S0016-5085(22)60871-0 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Russell, Lindsey
Armstrong, David
Sanchez, María Inés Pinto
Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title_full Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title_fullStr Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title_full_unstemmed Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title_short Sa1271: PATIENTS WITH CELIAC DISEASE HAVE NO INCREASED RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINE ADMINISTRATION COMPARED WITH NON-CELIAC CONTROLS
title_sort sa1271: patients with celiac disease have no increased rate of adverse events after covid-19 vaccine administration compared with non-celiac controls
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212270/
http://dx.doi.org/10.1016/S0016-5085(22)60871-0
work_keys_str_mv AT russelllindsey sa1271patientswithceliacdiseasehavenoincreasedrateofadverseeventsaftercovid19vaccineadministrationcomparedwithnonceliaccontrols
AT armstrongdavid sa1271patientswithceliacdiseasehavenoincreasedrateofadverseeventsaftercovid19vaccineadministrationcomparedwithnonceliaccontrols
AT sanchezmariainespinto sa1271patientswithceliacdiseasehavenoincreasedrateofadverseeventsaftercovid19vaccineadministrationcomparedwithnonceliaccontrols

Ejemplares similares